Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of HCC With PVTT
NCT05022628Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Sep 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of donafenib in hepatocellular carcinoma (HCC), sponsored by The First Affiliated Hospital of USTC. Status: unknown.
02
Drugs
donafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05022628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022628.